BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 33771361)

  • 1. The placenta and preeclampsia: villain or victim?
    Melchiorre K; Giorgione V; Thilaganathan B
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S954-S962. PubMed ID: 33771361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.
    Yagel S; Cohen SM; Goldman-Wohl D
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular origins of preeclampsia.
    Kalafat E; Thilaganathan B
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):383-389. PubMed ID: 28961633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine and fetal placental Doppler indices are associated with maternal cardiovascular function.
    Tay J; Masini G; McEniery CM; Giussani DA; Shaw CJ; Wilkinson IB; Bennett PR; Lees CC
    Am J Obstet Gynecol; 2019 Jan; 220(1):96.e1-96.e8. PubMed ID: 30243605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Sequels During and After Preeclampsia.
    Paauw ND; Lely AT
    Adv Exp Med Biol; 2018; 1065():455-470. PubMed ID: 30051401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between hypertensive disorders in pregnancy and placental maternal and fetal vascular circulation.
    Kovo M; Bar J; Schreiber L; Shargorodsky M
    J Am Soc Hypertens; 2017 Nov; 11(11):724-729. PubMed ID: 28967550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.
    Rana S; Burke SD; Karumanchi SA
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1019-S1034. PubMed ID: 33096092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of soluble endoglin in the maternal circulation are associated with maternal vascular malperfusion lesions in the placenta of women with preeclampsia.
    Schmella MJ; Assibey-Mensah V; Parks WT; Roberts JM; Jeyabalan A; Hubel CA; Catov JM
    Placenta; 2019 Mar; 78():29-35. PubMed ID: 30955708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia.
    Staff AC; Fjeldstad HE; Fosheim IK; Moe K; Turowski G; Johnsen GM; Alnaes-Katjavivi P; Sugulle M
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S895-S906. PubMed ID: 32971013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.
    Furuya M; Ishida J; Aoki I; Fukamizu A
    Vasc Health Risk Manag; 2008; 4(6):1301-13. PubMed ID: 19337544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental bed research: II. Functional and immunological investigations of the placental bed.
    Harris LK; Benagiano M; D'Elios MM; Brosens I; Benagiano G
    Am J Obstet Gynecol; 2019 Nov; 221(5):457-469. PubMed ID: 31288009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors.
    Tomimatsu T; Mimura K; Matsuzaki S; Endo M; Kumasawa K; Kimura T
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hypertension and superimposed preeclampsia: screening and diagnosis.
    Kametas NA; Nzelu D; Nicolaides KH
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1182-S1195. PubMed ID: 35177217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction.
    Granger JP; Alexander BT; Llinas MT; Bennett WA; Khalil RA
    Hypertension; 2001 Sep; 38(3 Pt 2):718-22. PubMed ID: 11566964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction.
    Jurisic A; Jurisic Z; Lefkou E; Girardi G
    Vascul Pharmacol; 2021 Apr; 137():106824. PubMed ID: 33249273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental Dysfunction as a Key Element in the Pathogenesis of Preeclampsia.
    Schneider H
    Dev Period Med; 2017; 21(4):309-316. PubMed ID: 29291358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
    Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
    Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal Vascular Malperfusion and Adverse Perinatal Outcomes in Low-Risk Nulliparous Women.
    Wright E; Audette MC; Ye XY; Keating S; Hoffman B; Lye SJ; Shah PS; Kingdom JC
    Obstet Gynecol; 2017 Nov; 130(5):1112-1120. PubMed ID: 29016509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition.
    Chang KJ; Seow KM; Chen KH
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.